Peptide Sequence: IGDEFNAYYAR
1.1 MW, m/z for 2+ and 3+ Charge States, pl
MW | m/z for 2+ | m/z for 3+ | pI |
---|---|---|---|
1317.67759 | 658.84607 | 440.23314 | 4.14 |
1.2 Fragment Ion Table
AA | b Series | b Ion Mass | y Series | y Ion Mass |
---|---|---|---|---|
I | b1 | 114.09188 | y11 | 1318.60675 |
G | b2 | 171.11334 | y10 | 1205.52269 |
D | b3 | 286.14028 | y9 | 1148.50124 |
E | b4 | 415.18287 | y8 | 1033.47430 |
F | b5 | 562.25128 | y7 | 904.43170 |
N | b6 | 676.29421 | y6 | 757.36330 |
A | b7 | 747.33132 | y5 | 643.32036 |
Y | b8 | 910.39465 | y4 | 572.28326 |
Y | b9 | 1073.45798 | y3 | 409.21992 |
A | b10 | 1144.49509 | y2 | 246.15659 |
R | - | y1 | 175.11948 |
2.1 MW m/z for 2+ and 3+ Charge States, pl, Label Location and Identity (e.g. 13C6-Leu)
IGDEFNAYY(13C915N1)AR
MW | m/z for 2+ | m/z for 3+ | pI |
---|---|---|---|
1327.62615 | 664.82035 | 443.54933 | 4.14 |
2.2 Fragment Ion Table
IGDEFNAYY(13C915N1)AR
AA | b Series | b Ion Mass | y Series | y Ion Mass |
---|---|---|---|---|
I | b1 | 114.09188 | y11 | 1328.63395 |
G | b2 | 171.11334 | y10 | 1215.54989 |
D | b3 | 286.14028 | y9 | 1158.52843 |
E | b4 | 415.18287 | y8 | 1043.50149 |
F | b5 | 562.25128 | y7 | 914.45890 |
N | b6 | 676.29421 | y6 | 767.39049 |
A | b7 | 747.33132 | y5 | 653.34756 |
Y | b8 | 910.39465 | y4 | 582.31045 |
Y | b9 | 1083.48518 | y3 | 419.24712 |
A | b10 | 1154.52229 | y2 | 246.15659 |
R | - | y1 | 175.11948 |
2.3 MALDI MS and MS/MS of LC Purified Peptide
2.4 QqQ MS/MS
2.5 Calibration Curve of Standard
2.6 LC-MRM Analysis of 1-3 Biological Samples Using 10,000 Cells
(No such data yet for peptide IDGEFNAYYAR)
© Copyright 2008 Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute